Trials / Completed
CompletedNCT03782701
The Effect of Lumify™ Eyedrops on Eyelid Position
The Effect of Lumify™ (Brimonidine Tartrate Ophthalmic Solution 0.025%) on Palpebral Fissure Height
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the research is to see if Lumify™ has an effect on eyelid position.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brimonidine tartrate ophthalmic solution 0.025% | One time dosing of brimonidine tartrate ophthalmic solution 0.025% (1 drop applied to ocular surface) |
| OTHER | Sterile balanced saline solution | One time dosing of sterile balanced saline solution (1 drop applied to ocular surface) |
Timeline
- Start date
- 2019-06-18
- Primary completion
- 2020-04-01
- Completion
- 2020-04-01
- First posted
- 2018-12-20
- Last updated
- 2021-06-14
- Results posted
- 2021-06-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03782701. Inclusion in this directory is not an endorsement.